vs

Side-by-side financial comparison of GrowGeneration Corp. (GRWG) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $37.8M, roughly 2.0× GrowGeneration Corp.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 1.0%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -11.1%).

GrowGeneration Corp is a leading U.S.-based specialty retailer of hydroponics and organic gardening supplies. It offers a full portfolio of products including grow lights, nutrient solutions, climate control systems and cultivation tools, serving both commercial indoor farming operators (including legal cannabis cultivators) and hobbyist home gardeners via its nationwide physical store network and e-commerce channels.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

GRWG vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
2.0× larger
PBYI
$75.5M
$37.8M
GRWG
Growing faster (revenue YoY)
PBYI
PBYI
+26.7% gap
PBYI
27.7%
1.0%
GRWG
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-11.1%
GRWG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRWG
GRWG
PBYI
PBYI
Revenue
$37.8M
$75.5M
Net Profit
$-7.4M
Gross Margin
24.1%
69.3%
Operating Margin
-20.1%
22.7%
Net Margin
-19.6%
Revenue YoY
1.0%
27.7%
Net Profit YoY
68.2%
EPS (diluted)
$-0.12
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRWG
GRWG
PBYI
PBYI
Q4 25
$37.8M
$75.5M
Q3 25
$47.3M
$54.5M
Q2 25
$41.0M
$52.4M
Q1 25
$35.7M
$46.0M
Q4 24
$37.4M
$59.1M
Q3 24
$50.0M
$80.5M
Q2 24
$53.5M
$47.1M
Q1 24
$47.9M
$43.8M
Net Profit
GRWG
GRWG
PBYI
PBYI
Q4 25
$-7.4M
Q3 25
$-2.4M
$8.8M
Q2 25
$-4.8M
$5.9M
Q1 25
$-9.4M
$3.0M
Q4 24
$-23.3M
Q3 24
$-11.4M
$20.3M
Q2 24
$-5.9M
$-4.5M
Q1 24
$-8.8M
$-4.8M
Gross Margin
GRWG
GRWG
PBYI
PBYI
Q4 25
24.1%
69.3%
Q3 25
27.2%
77.7%
Q2 25
28.3%
76.5%
Q1 25
27.2%
77.1%
Q4 24
16.4%
76.4%
Q3 24
21.6%
63.9%
Q2 24
26.9%
77.4%
Q1 24
25.8%
75.5%
Operating Margin
GRWG
GRWG
PBYI
PBYI
Q4 25
-20.1%
22.7%
Q3 25
-6.0%
17.6%
Q2 25
-12.9%
12.7%
Q1 25
-27.7%
8.7%
Q4 24
-63.9%
22.6%
Q3 24
-24.2%
27.4%
Q2 24
-12.2%
-4.6%
Q1 24
-19.7%
-5.3%
Net Margin
GRWG
GRWG
PBYI
PBYI
Q4 25
-19.6%
Q3 25
-5.2%
16.2%
Q2 25
-11.7%
11.2%
Q1 25
-26.3%
6.5%
Q4 24
-62.4%
Q3 24
-22.9%
25.2%
Q2 24
-11.0%
-9.6%
Q1 24
-18.5%
-11.0%
EPS (diluted)
GRWG
GRWG
PBYI
PBYI
Q4 25
$-0.12
$0.26
Q3 25
$-0.04
$0.17
Q2 25
$-0.08
$0.12
Q1 25
$-0.16
$0.06
Q4 24
$-0.39
$0.40
Q3 24
$-0.19
$0.41
Q2 24
$-0.10
$-0.09
Q1 24
$-0.14
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRWG
GRWG
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$46.1M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$97.5M
$130.3M
Total Assets
$147.0M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRWG
GRWG
PBYI
PBYI
Q4 25
$46.1M
$97.5M
Q3 25
$48.3M
$94.4M
Q2 25
$48.7M
$96.0M
Q1 25
$52.6M
$93.2M
Q4 24
$56.5M
$101.0M
Q3 24
$55.2M
$96.7M
Q2 24
$56.0M
$96.8M
Q1 24
$61.3M
$107.2M
Total Debt
GRWG
GRWG
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
GRWG
GRWG
PBYI
PBYI
Q4 25
$97.5M
$130.3M
Q3 25
$104.7M
$115.3M
Q2 25
$106.7M
$104.7M
Q1 25
$111.2M
$97.1M
Q4 24
$120.1M
$92.1M
Q3 24
$143.2M
$71.1M
Q2 24
$155.8M
$48.5M
Q1 24
$165.3M
$51.0M
Total Assets
GRWG
GRWG
PBYI
PBYI
Q4 25
$147.0M
$216.3M
Q3 25
$159.6M
$202.9M
Q2 25
$160.6M
$194.9M
Q1 25
$164.2M
$196.2M
Q4 24
$174.4M
$213.3M
Q3 24
$199.6M
$220.7M
Q2 24
$219.2M
$205.0M
Q1 24
$230.4M
$214.1M
Debt / Equity
GRWG
GRWG
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRWG
GRWG
PBYI
PBYI
Operating Cash FlowLast quarter
$-2.2M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRWG
GRWG
PBYI
PBYI
Q4 25
$-2.2M
$14.4M
Q3 25
$-499.0K
$9.7M
Q2 25
$-2.9M
$14.1M
Q1 25
$-3.8M
$3.6M
Q4 24
$1.1M
$15.6M
Q3 24
$1.2M
$11.0M
Q2 24
$-398.0K
$1.0M
Q1 24
$-3.6M
$11.2M
Free Cash Flow
GRWG
GRWG
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
GRWG
GRWG
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
GRWG
GRWG
PBYI
PBYI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
GRWG
GRWG
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRWG
GRWG

Consumables$22.3M59%
Durables$9.8M26%
Commercial Fixture Sales$5.7M15%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons